Human Genetics PhD @HopkinsMedicine. F31 fellow studying immunology and single-cell genomics in pancreatic cancer. @FertigLab

Baltimore, MD
RT @moderna_tx: mRNA-4157/V940 is an investigational personalized #cancer #vaccine consisting of a single #mRNA coding for up to 34 neoanti…
28
Emily Davis-Marcisak, PhD retweeted
New🔥 #DataScience #Bioinformatics resource: 850,000‼️ #scRNAseq cells from 226 samples across 10 cancer types draw a map of the tumor microenvironment, in particular fibroblasts. Let’s see👇what are the main contributions of this work & what this means for #cancer #Genomics🧵
6
158
729
Emily Davis-Marcisak, PhD retweeted
It’s spatial profiling day on @biorxivpreprint! Now @10xGenomics out with a preprint on integrated single cell, spatial and in situ analysis of FFPE tissue. Very excited by the extension of these high dimensional technologies to archival samples! biorxiv.org/content/10.1101/…
5
49
202
Emily Davis-Marcisak, PhD retweeted
Presenting Slide-TCR-seq: our method for measuring the transcriptomes of cells & T cell receptor (TCR) sequences in situ! This collaboration w/ Bryan Iorgulescu, Shuqiang Li, Catherine Wu, and @insitubiology led to some cool findings... cell.com/immunity/fulltext/S… 1/8
16
191
741
Emily Davis-Marcisak, PhD retweeted
Cancer #immunotherapy #DataScience resource of the week: #scRNAseq & #scTCRseq atlas of 400,000‼️T cells from 316 patients of 21 cancer types, derived from tumors, adjacent normal tissue, and peripheral blood.Half of data newly sequenced, half gathered from literature. 🧵(1/4)
7
137
507
Emily Davis-Marcisak, PhD retweeted
The most recent paper from the lab has been published at @jitcancer. We employed single-cell mass cytometry to delineate tumor-associated and systemic immune profiles in #PancreaticCancer. jitc.bmj.com/content/10/7/e0…
1
8
26
Emily Davis-Marcisak, PhD retweeted
“This grant proposal describes breeding experiments in peas. This reviewer remains unconvinced about the translational benefits. Applicant should switch to a more economically important crop like wheat. Applicant’s productivity also an issue, no paper published in last 8 years”.
29
363
1,907
Emily Davis-Marcisak, PhD retweeted
ICYMI @TheVinodLab @MSKCancerCenter recent adjuvant trial of an mRNA #vaccine in patients with #PancreaticCancer (a collaboration with @BioNTech_Group) was featured on @cnn (@drsanjaygupta).
Even before mRNA was used for a covid vaccine, researchers @BioNTech_Group were using the technology to develop customized cancer treatments. A vaccine for cancer…? Not quite, but close. Here is how it works:
14
42
Emily Davis-Marcisak, PhD retweeted
Here's a neat tech, where they capture T cells based on adherence to target tumour cells in a microfluidic device: doi.org/10.1002/adhm.2022001… A fast assay that addresses a lot of problems from say sticky multimers, and twiddling the pressure lets you sort out high avidity binders.
1
2
16
Emily Davis-Marcisak, PhD retweeted
Minimize the chances of missing a T cell population critical to your therapy success!💪🏼 OS-T enables #TCR #sequencing of up to #1M #cells per sample at cellular resolution. Submit your #abstract and opt-in to an opportunity to be awarded 4 free samples! omniscope.ai/abstract-submis…
1
11
14
Emily Davis-Marcisak, PhD retweeted
So lucky to have been able to work with @efaithd an incredibly talented, creative and overall amazing scientist! I have no doubt you will continue to do incredible work. Congratulations!
I earned my PhD yesterday! In person too! What a surreal feeling all around. Wildly thankful for my incredible mentors on this journey, @FertigLab @NeehaZaidi @DrLizJaffee and everyone who made this possible.
2
7
Emily Davis-Marcisak, PhD retweeted
How do different routes of #mRNA vaccination (made by @Tibabiotech) impact the differentiation and distribution of #vaccine elicited CD8 and CD4 T cell memory responses in mice? @TwiterlessBuck @Masopust_Vezys @niaidcivics 👇🏼 biorxiv.org/content/10.1101/…
4
31
137
Emily Davis-Marcisak, PhD retweeted
Our immune system follows circadian rhythm. A new review @SciImmunology. And why getting Covid vaccines in the morning elicits a better antibody and cellular immune response science.org/doi/10.1126/scii… @ScheiermannLab
32
376
1,101
I earned my PhD yesterday! In person too! What a surreal feeling all around. Wildly thankful for my incredible mentors on this journey, @FertigLab @NeehaZaidi @DrLizJaffee and everyone who made this possible.
3
1
40
Emily Davis-Marcisak, PhD retweeted
It's a @NEJM case report, but a groundbreaking one. For a woman with refractory pancreatic cancer, genetically engineered T cells directed towards the KRAS driver mutation achieved substantial tumor regression nejm.org/doi/full/10.1056/NE…
24
420
1,645
Emily Davis-Marcisak, PhD retweeted
Head-to-head comparison of immune response, both antibody and cellular, for 4 vaccines: Moderna, Pfizer, Novavax and J&J cell.com/cell/fulltext/S0092… @CellCellPress @profshanecrotty @ljiresearch @zhang_zeli @jmateust @camilahcoelho @SetteLab
28
308
807